Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio Growth (3y) (2015 - 2025)
Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.99% |
| Jun 30, 2025 | 9.14% |
| Mar 31, 2025 | -227.38% |
| Dec 31, 2024 | -192.43% |
| Sep 30, 2024 | -99.77% |
| Jun 30, 2024 | 27.99% |
| Mar 31, 2024 | -0.60% |
| Dec 31, 2023 | -137.42% |
| Sep 30, 2023 | 544.28% |
| Jun 30, 2023 | -186.66% |
| Dec 31, 2022 | -113.62% |
| Jun 30, 2022 | -121.02% |
| Mar 31, 2022 | -259.31% |
| Dec 31, 2021 | -44.49% |
| Sep 30, 2021 | -84.83% |
| Jun 30, 2021 | -171.27% |
| Mar 31, 2021 | -111.59% |
| Dec 31, 2020 | -77.55% |
| Sep 30, 2020 | -47.40% |
| Jun 30, 2020 | -1.03% |